All Posts

WASHINGTON — Select Subcommittee on the Coronavirus Pandemic Chairman Brad Wenstrup (R-Ohio) will hold a hearing titled “Oh Doctor, Where Art Thou? Pandemic Erosion of the Doctor-Patient Relationship” to examine the importance of the doctor-patient relationship during times of crisis, including future pandemics. Select Subcommittee members and expert witnesses will explore how government overreach during the COVID-19 pandemic, coupled with one-size-fits-all protocols promoted by ...

WASHINGTON— Subcommittee on Cybersecurity, Information Technology, and Government Innovation Chairwoman Nancy Mace (R-S.C.) will hold a hearing titled “How are Federal Agencies Harnessing Artificial Intelligence?” The hearing will examine whether federal agencies are ready to harness the powerful benefits of AI to transform government operations. This hearing will explore ...

WASHINGTON—House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) and Rep. Marjorie Taylor Greene (R-Ga.) are today renewing their probe into the Department of Justice’s (DOJ) potential failure to uphold the rights of victims who were sexually exploited by Hunter Biden. In a letter to top officials at DOJ, the lawmakers warn that DOJ’s decision to ignore the Committee’s initial inquiry flies in the face of the agency’s own policies and renew their request for ...

WASHINGTON—Subcommittee on Government Operations and the Federal Workforce Chairman Pete Sessions (R-Texas) will hold a hearing titled “Oversight of Federal Agencies’ Post-Pandemic Telework Policies.” The hearing will examine the Biden Administration’s post-pandemic telework and remote work policies for federal employees. “The Biden Administration has ...

WASHINGTON—Subcommittee on Health Care and Financial Services Chairwoman Lisa (R-Mich.) today announced a hearing titled “The Inflation Reduction Act: A Year in Review” to examine the impacts of President Biden’s Inflation Reduction Act (IRA) on the economy, American taxpayers, and small businesses. The IRA hiked taxes on businesses, mandated price controls on drugs, devoted $80 billion ...